There has recently been a flurry of articles and forum letters in The Straits Times discussing the impact of a new Cancer Drug List policy on patients with cancer.
It comes into effect in September for people with MediShield Life and for MediSave withdrawals, and in April next year for those with Integrated Shield Plans (IPs).
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
